140 units, the "new king" of image collection makes a comeback

Recently, the results of a batch of imaging equipment procurement by Chongqing Cancer Research Institute were announced. The project had a budget of over 110 million yuan, including 161 pieces of equipment. It was eventually sold for 40.478 million yuan, achieving a savings rate of 64%.

Among them, Anjian won the bid for 140 pieces of equipment and became the biggest winner. Blue Shadow, Shandong Xinhua, Neusoft Medical and Meiya Optoelectronics also made gains.

01

3586.3万

安健，拿下

In the results announced this time, Anjian won a total of 140 DRS, with unit prices ranging from 230,000 to 530,000 yuan, and the total amount of the bid was 35.863 million yuan.

It is reported that Anjian Technology is the first DR Manufacturer in China to independently research and produce five core components, and it has also developed the first dynamic flat panel detector in China. China's first dynamic digital X-ray machine; The first mobile dynamic function DR It has achieved a number of internationally leading technologies such as dynamic imaging of organ functions and dynamic imaging of motor functions, leading the Chinese DR Industry towards dynamic development.

2025年H1 DR品牌市占率（台数）

Data shows that in the first half of this year, in terms of the number of units, Wandong Medical held a 34% market share, far ahead of others and ranking first in the DR Market. Blue Shadow and United Imaging Medical ranked second and third respectively. Anjian Technology has a market share of approximately 8% and ranks fourth in the market.

Market share (amount) of DR Brand in H1 2025

In terms of market share, Wandong has a 21% share, United Imaging 18%, and Anjian 8%, ranking among the top three in the market.

Domestic DR Equipment has basically achieved domestic production, with a domestic production rate of about 80%, and has gradually reduced its reliance on international manufacturers in core components such as detectors.

02

DR Centralized procurement has been launched in many places. Who will be the big winner?

In early 2025, the National Development and Reform Commission and the Ministry of Finance jointly issued the "Notice of the Ministry of Finance on Intensifying and Expanding the Implementation of Large-scale Equipment Renewal and Consumer Goods Trade-in Policies in 2025", clearly stating that they will strengthen financial support. The policy dividends will promote the further expansion of the domestic medical imaging equipment market size.

Against this backdrop, many regions have launched centralized procurement of medical imaging equipment such as DR.

Wan Dong emerged as the biggest winner in a 170 million yuan deal in Henan Province

In June, the results of the DR Centralized procurement by the Health Commission of Henan Province were announced. This project involves 213 sets of DRS, including 129 suspended DRS and 84 column-mounted DRS, with a total budget of nearly 170 million yuan.

Ultimately, the winning bid amount was 74.97 million yuan, with a reduction of more than half. Wandong Medical won 133 bids with a total amount of 49.77 million yuan, emerging as the biggest winner. Neusoft won the bid for 34 units with a total amount of 11.25 million yuan. Anjian won the bid for 32 units, with a total amount of 9.414 million yuan. Blue Shadow won the bid for 14 units, with a total bid amount of 4.536 million yuan.

Ningxia centralized Procurement, Lanying Independent High Sch

In June, the results of a batch of DR Centralized procurement by the Health Commission of Ningxia were announced. The project includes 76 DR Sets with a total budget of 52.35 million yuan. Ultimately, Lanying DR Equipment won all 76 sets of DR Purchases, with a total winning bid amount of 14.86 million yuan and a price reduction of over 70%.

In Xinjiang's centralized procurement, Wandong alone secured 267 units

In May, the Xinjiang Health Commission announced the centralized procurement of 267 sets of DR. The total budget for this project is 92.32 million yuan. It includes 187 sets of suspended double-board equipment, 5 sets of mobile DR Equipment, and 75 sets of double-column DR Equipment.

Ultimately, the winning bid amount was 52.365 million yuan. Wandong has secured the purchase of all 267 DR Sets.

Blue Shadow, the big winner of Hunan's centralized procurement

In May, the results of the centralized procurement of CT and DR For county-level medical communities in Hunan Province were announced. This project includes 88 sets of 32-slice CT equipment and 187 sets of DR Equipment, with a total budget of nearly 280 million yuan.

The final winning bid amount was approximately 150 million yuan. Blue Shadow has won 94 DR Sets (the project's maximum limit price is 70.5 million yuan, the total winning bid price is 33.84 million yuan, and the average unit price is 360,000 yuan). Wandong won the bid for 93 DR Sets (with a maximum limit price of 69.75 million yuan, a total winning bid price of 29.4438 million yuan, and an average unit price of 316,600 yuan).

Mindray's 32 units emerged as the big winner in the Hainan centralized procurement project

In March this year, the Health Commission of Hainan Province announced the winning results of the 54 sets of DR Centralized procurement project it carried out. This project is divided into 6 packages, including 54 sets of DR. Among them, there are 38 sets of suspended DR, 10 sets of ordinary DR And 6 sets of mobile DR. The total budget for the project is 60.78 million yuan.

Ultimately, the total amount of the winning bid was 32.709 million yuan, and the price was basically halved. Mindray DR Equipment monopolized the procurement of 32 sets of DR Equipment and won a bid of 17.015 million yuan, becoming the biggest winner. United Imaging won the bid for 17 sets of DR Equipment, with a total bid value of 13.43 million yuan. Anjian DR Equipment won the bid for 4 sets, with a bid value of 2.264 million yuan. One set of DR Procurement bid is invalid.

——

In terms of per capita ownership, the configuration level of DR Equipment in China is still significantly lower than that in developed countries. In 2019, the number of DR Units per million people in China was approximately 43.5, which was only a quarter of the level in the United States during the same period (about 172 units per million people in the United States). With the rising demand for chronic and orthopedic disease examinations brought about by population aging, the promotion of equipment replenishment in primary medical institutions by the hierarchical medical treatment policy, and the rapid development of private hospitals and third-party imaging centers, DR, as a basic imaging device, will continue to benefit. In 2019, the market size of DR In China was approximately 7.89 billion yuan. In 2020, driven by the pandemic, the demand soared to 10.53 billion yuan. It is projected that the market size will reach 19.68 billion yuan by 2030, with a compound annual growth rate of 6.5%.